MSA
INFI

Mason Street Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Mason Street Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-110,180
Closed -$1.52M – 1890
2013
Q4 		$1.52M Hold
110,180
– – 0.01% 1048
2013
Q3 		$1.92M Buy
+110,180
New +$2.11M 0.02% 730

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Mason Street Advisors's INFI Position: Q1 2014 in Review

Mason Street Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2014, closing a stake of 110,180 shares — an estimated $1.52M sold.

Mason Street Advisors first reported a position in INFI in Q3 2013 and held it in 2 quarters. The position peaked at $1.92M in Q3 2013. 98 funds tracked by Wall St. Rank hold INFI as of Q1 2014.

  • Mason Street Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Mason Street Advisors sold 110,180 Infinity Pharmaceuticals, Inc. shares in Q1 2014, an estimated $1.52M.
  • Mason Street Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2013 and held it in 2 quarters.
  • Mason Street Advisors's Infinity Pharmaceuticals, Inc. position peaked at $1.92M in Q3 2013.
  • 98 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2014.

Based on Mason Street Advisors's 13F filing for Q1 2014, filed 15 May 2014.